Mahamaya Lifesciences IPO Date, Review, Price, Allotment Details
Mahamaya Lifesciences IPO is offering its shares to the public for the first time through an IPO on the stock exchanges BSE SME. The total amount they aim to raise is 61,78,800 shares (aggregating up to ₹70.44 Cr). Out of this 58,69,200 shares (aggregating up to ₹66.91 Cr) will be through new shares, and 5,40,000 shares of ₹10 (aggregating up to ₹6.16 Cr) through existing shares. The IPO is open for subscription from 11 November, 2025 to 13 November, 2025. Each share has a face value of Rs 10, and investors can apply for shares at a price between ₹108 to ₹114 per share. The minimum number of shares one can apply for is 1200, or multiples of that as mentioned in the offer document.
|
Check Live IPO GMP List 👈
|
|
Check Live IPO Subscription List 👈
|
|
Check All IPO Allotment List 👈
|
| Last Day |
Mahamaya Lifesciences IPO Details
| IPO Category Type: | SME |
| IPO Open: | 11 November, 2025 |
| IPO Close: | 13 November, 2025 |
| IPO Price Band: | ₹108 to ₹114 per share |
| Face Value: | ₹10 Per Equity Share |
| IPO Listing on: | BSE SME |
| IPO Issue Type: | Book Build Issue |
| IPO Size: | Approx 61,78,800 shares (aggregating up to ₹70.44 Cr) |
| Fresh Issue: | Approx 58,69,200 shares (aggregating up to ₹66.91 Cr) |
| Offer for Sale: | Approx 5,40,000 shares of ₹10 (aggregating up to ₹6.16 Cr) |
Mahamaya Lifesciences IPO Reservation
| Retail Quota: | 33.33% |
| QIB Quota: | 47.39% |
| NII Quota: | 14.27% |
| Employee Discount: | [.] |
Mahamaya Lifesciences IPO Prospectus
| DRHP Draft Prospectus: | Continue Reading |
| RHP Draft Prospectus: | Continue Reading |
| Anchor Investors List: | [.] |
Mahamaya Lifesciences IPO Market Lot Details
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| 1 | 1200 | ₹136800 |
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2400 | 273600 |
| Individual investors (Retail) (Max) | 2 | 2400 | 273600 |
| S-HNI (Min) | 3 | 3600 | 410400 |
| S-HNI (Max) | 7 | 8400 | 957600 |
| B-HNI (Min) | 8 | 9600 | 1094400 |
Mahamaya Lifesciences IPO Dates
| IPO Activity | Date |
|---|---|
| Open Date: | 11 November, 2025 |
| Close Date: | 13 November, 2025 |
| Allotment Date: | 14 November, 2025 |
| Refund Date: | 17 November, 2025 |
| Shares Credit Date: | 17 November, 2025 |
| Listing Date: | 18 November, 2025 |
Mahamaya Lifesciences Company Financial Report
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| Total Income | 84.04 | 267.17 | 162.83 | 137.40 |
| Profit After Tax | 4.10 | 12.94 | 5.22 | 3.75 |
| EBITDA | 8.04 | 24.64 | 13.36 | 8.91 |
| NET Worth | 53.50 | 49.42 | 24.66 | 19.44 |
| Reserves and Surplus | 35.73 | 31.66 | 23.41 | 18.19 |
| Total Borrowing | 57.72 | 58.11 | 54.63 | 24.37 |
| Amount in ₹ Crore | ||||
Mahamaya Lifesciences Company Address
| Company | Mahamaya Lifesciences Ltd. |
|---|---|
| Address | Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1 Delhi, New Delhi, 110020 |
| Phone | +91-1146561474 |
| cs@mahamayalifesciences.com | |
| Website | https://www.mahamayalifesciences.com/ |
Mahamaya Lifesciences IPO Registrar
| Company | Kfin Technologies Ltd. |
|---|---|
| Phone | 04067162222, 04079611000 |
| mahamaya.ipo@kfintech.com | |
| Website | https://ipostatus.kfintech.com/ |
Mahamaya Lifesciences IPO Lead Manager
- Oneview Corporate Advisors Pvt.Ltd.
Mahamaya Lifesciences IPO KPI
| KPI | Values |
|---|---|
| ROE | 34.94% |
| ROCE | 23.15% |
| Debt/Equity | 1.08 |
| RoNW | 26.19% |
| PAT Margin | 4.84% |
| EBITDA Margin | 9.22% |
| Price to Book Value | 9.40 |
| Market Capitalization | 266.82 |
Mahamaya Lifesciences IPO - FAQs
Q.What is Mahamaya Lifesciences IPO?
Ans.Mahamaya Lifesciences IPO is a SME IPO. The IPO is list on BSE SME. The total amount Mahamaya Lifesciences aim to raise is 61,78,800 shares (aggregating up to ₹70.44 Cr).
Q.When Mahamaya Lifesciences IPO will open?
Ans.Mahamaya Lifesciences IPO is to open on 11 November, 2025 for Investors.
Q.What is Mahamaya Lifesciences IPO Investors Portion?
Ans.Mahamaya Lifesciences investor's portion for QIB is 47.39%, NII is 14.27%, and Retail is 33.33%.
Q.What is Mahamaya Lifesciences IPO Size?
Ans.Mahamaya Lifesciences IPO size is 61,78,800 shares (aggregating up to ₹70.44 Cr).
Q.What is Mahamaya Lifesciences IPO Price Band?
Ans.Mahamaya Lifesciences IPO Price Band is ₹108 to ₹114 per share.
Q.What is the Mahamaya Lifesciences IPO Allotment Date?
Ans.Mahamaya Lifesciences IPO allotment date is 14 November, 2025.
Q.What is the Mahamaya Lifesciences IPO Listing Date?
Ans.Mahamaya Lifesciences IPO listing date is 18 November, 2025. The IPO is to list on BSE SME.